Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Raw Materials (2022 - 2025)

Envoy Medical's Raw Materials history spans 4 years, with the latest figure at $1.3 million for Q4 2025.

  • Quarterly results put Raw Materials at $1.3 million for Q4 2025, down 8.95% from a year ago — trailing twelve months through Dec 2025 was $1.3 million (down 8.95% YoY), and the annual figure for FY2025 was $1.3 million, down 8.95%.
  • Raw Materials for Q4 2025 was $1.3 million at Envoy Medical, down from $1.4 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $1.4 million in Q1 2025 to a low of $1.0 million in Q4 2022.
  • The 4-year median for Raw Materials is $1.4 million (2024), against an average of $1.3 million.
  • The sharpest move saw Raw Materials increased 19.28% in 2024, then dropped 8.95% in 2025.
  • Year by year, Raw Materials stood at $1.0 million in 2022, then grew by 15.05% to $1.2 million in 2023, then grew by 19.28% to $1.4 million in 2024, then dropped by 8.95% to $1.3 million in 2025.
  • According to Business Quant data, Raw Materials over the past three periods came in at $1.3 million, $1.4 million, and $1.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.